Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Infection

imatinib mesylate has been researched along with Infection in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ammerlaan, RA; Chu, IW; Cornelissen, JJ; Deenik, W; Falkenburg, JH; Janssen, JJ; Kersten, MJ; Ossenkoppele, GJ; Schattenberg, A; Schipperus, M; Sinnige, HA; Smit, WM; Sonneveld, P; Thielen, N; Valk, PJ; van der Holt, B; van Marwijk Kooy, R; Verhoef, GE1
Demoulin, JB; Essaghir, A1
Belknap, SM; Bennett, CL; Boyle, S; Burdon, R; Djulbegovic, B; Dorr, DA; Edwards, BJ; Georgopoulos, C; Lagman, J; McKoy, JM; Sartor, O; Tallman, MS; Talpaz, M; Weitzman, SA; West, DP1
Kizaki, M1

Reviews

2 review(s) available for imatinib mesylate and Infection

ArticleYear
PDGF receptor signaling networks in normal and cancer cells.
    Cytokine & growth factor reviews, 2014, Volume: 25, Issue:3

    Topics: Benzamides; Fibrosis; Gastrointestinal Stromal Tumors; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Infections; Leukemia; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Stroke

2014
New therapeutic approach for myeloid leukemia: induction of apoptosis via modulation of reactive oxygen species production by natural compounds.
    International journal of hematology, 2006, Volume: 83, Issue:4

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzamides; Hemorrhage; Humans; Imatinib Mesylate; Infections; Leukemia, Myeloid, Acute; Piperazines; Pyrimidines; Reactive Oxygen Species

2006

Trials

1 trial(s) available for imatinib mesylate and Infection

ArticleYear
High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group.
    Annals of hematology, 2013, Volume: 92, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cytarabine; Disease-Free Survival; Early Termination of Clinical Trials; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Imatinib Mesylate; Infections; Kaplan-Meier Estimate; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Pain; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sample Size; Treatment Outcome; Young Adult

2013

Other Studies

1 other study(ies) available for imatinib mesylate and Infection

ArticleYear
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jun-01, Volume: 15, Issue:11

    Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Benzamides; Clinical Trials as Topic; Drug Utilization Review; Fractures, Bone; Heart Failure; Humans; Imatinib Mesylate; Infections; Neoplasms; Piperazines; Product Surveillance, Postmarketing; Professional Staff Committees; Pulmonary Edema; Pyrimidines; Time Factors

2009